AHNAK2 (AHNAK Nucleoprotein 2)

News alerts, weekly reports and conference planners

Entrez ID:

AHNAK2 mutation	Non Small Cell Lung Cancer	AHNAK2 mutation	Non Small Cell Lung Cancer	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3
AHNAK2 mutation + TP53 mutation	Non Small Cell Lung Cancer	AHNAK2 mutation + TP53 mutation	Non Small Cell Lung Cancer	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3
AHNAK2 mutation + TMB-H	Non Small Cell Lung Cancer	AHNAK2 mutation + TMB-H	Non Small Cell Lung Cancer	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3

Associations(3)